Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2010081131) COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 2 DIABETES
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/081131 International Application No.: PCT/US2010/020725
Publication Date: 15.07.2010 International Filing Date: 12.01.2010
Chapter 2 Demand Filed: 16.08.2010
IPC:
A61K 38/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
Applicants:
AMERICAN TYPE CULTURE COLLECTION [US/US]; 10801 University Boulevard Manassas, Virginia 20110, US (AllExceptUS)
GELBER, Cohava [US/US]; US (UsOnly)
LIU, Liping [US/US]; US (UsOnly)
XIE, Zhidong [US/US]; US (UsOnly)
IKONOMI, Pranvera [US/US]; US (UsOnly)
SIMMS, John, R. [US/US]; US (UsOnly)
AUGE, Catherine, R. [FR/US]; US (UsOnly)
Inventors:
GELBER, Cohava; US
LIU, Liping; US
XIE, Zhidong; US
IKONOMI, Pranvera; US
SIMMS, John, R.; US
AUGE, Catherine, R.; US
Agent:
RESNICK, David S; Nixon Peabody LLP 100 Summer Street Boston, Massachusetts 02110, US
Priority Data:
12/319,88312.01.2009US
Title (EN) COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 2 DIABETES
(FR) COMPOSITIONS ET PROCÉDÉS DE DIAGNOSTIC ET DE TRAITEMENT DU DIABÈTE DE TYPE 2
Abstract:
(EN) The present invention relates generally to the identification of biological markers associated with an increased risk of developing Diabetes, as well as methods of using such biological markers in diagnosis and prognosis of Diabetes. The biological markers of the invention may indicate new targets for therapy or constitute new therapeutics for the treatment or prevention of Diabetes.
(FR) La présente invention porte d'une manière générale sur l'identification de marqueurs biologiques associés à un risque accru de développer le diabète, ainsi que sur des procédés d'utilisation de tels marqueurs biologiques dans le diagnostic et le pronostic du diabète. Les marqueurs biologiques de l'invention peuvent indiquer de nouvelles cibles pour une thérapie ou constituer de nouveaux produits thérapeutiques pour le traitement ou la prévention du diabète.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)